Sanofi India (NSE:SANOFI) Buildings And Improvements : ₹2,539 Mil (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Sanofi India Buildings And Improvements?

Sanofi India's quarterly buildings and improvements stayed the same from Jun. 2023 (₹0 Mil) to Sep. 2023 (₹0 Mil) but then increased from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹2,539 Mil).

Sanofi India's annual buildings and improvements declined from Dec. 2021 (₹2,554 Mil) to Dec. 2022 (₹2,425 Mil) but then increased from Dec. 2022 (₹2,425 Mil) to Dec. 2023 (₹2,539 Mil).

Sanofi India Buildings And Improvements Historical Data

The historical data trend for Sanofi India's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India Buildings And Improvements Chart

Sanofi India Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

Get a 7-Day Free Trial

2,313.00

2,311.00

2,554.00

2,425.00

2,539.00

Sanofi India Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Buildings And Improvements	Get a 7-Day Free Trial															2,425.00	-	-	-	2,539.00

Sanofi India Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Sanofi India (NSE:SANOFI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (NSE:SANOFI) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

500674:India

Address

Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072

Website

https://www.sanofiindialtd.com

Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth strategy.

Sanofi India (NSE:SANOFI) Headlines

No Headlines